Starling Oncology, Inc.

STLN · Healthcare

$5.94

Capitalizzazione: 605.38M USDRendimento da dividendo: —
AdvanceÈ un buon momento per comprare Starling Oncology, Inc.? Chiedi a Copenvest AIOttieni un'analisi Advance con AI su timing, rischio e cosa fanno gli investitori tracciati.Chiedi a Copenvest AI

Caricamento grafico…

Notizie

Ultime notizie su questo titolo

GlobeNewswire24 ago 2026, 13:00

Starling Oncology to Participate in Wells Fargo Healthcare Conference

GlobeNewswire17 ago 2026, 12:00

Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale

MT Newswires7 ago 2026, 14:09

B. Riley Adjusts Price Target on Starling Oncology to $11 From $8, Maintains Buy Rating

Zacks6 ago 2026, 23:10

The Oncology Institute, Inc. (STLN) Reports Q2 Loss, Tops Revenue Estimates

GlobeNewswire6 ago 2026, 20:14

Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance